Maja Strozzi1, Darko Anić. 1. Department of Cardiology, Zagreb University Hospital Center, Zagreb, Croatia. maja.strozzi@zg.t-com.hr
Abstract
AIM: To compare polytetrafluoroethylene stent graft (PTFE) with sirolimus and bare metal stents in reducing in-stent restenosis in native coronary vessels in patients with acute coronary syndrome. METHODS: The study included patients who underwent stent implantation in acute coronary syndrome from January 2003 to May 2004. The patients (n=119) were randomized either to stent graft group (n=40), sirolimus eluting stent group (n=39), or bare metal stent group (n=40). The main outcome measure of the study was the incidence restenosis at 6-month. The secondary outcome was 6-month major adverse coronary event rate. RESULTS: The incidence of 6-month major adverse coronary events was similar in all three groups (8 events in stent graft, 9 in sirolimus eluting stent, and 16 in bare metal stent group events). The target lesion revascularization was higher in the bare metal stent group (P=0.044). Restenosis rate, at six-month follow-up was higher in the bare metal stent group compared with the stent graft and sirolimus eluting stent groups. The percent diameter stenosis in the follow-up was significantly higher in the bare metal stent group (P=0.005). The late loss was significantly lower in the sirolimus eluting stent group (mean+/-standard deviation, 0.2+/-0.5 mm), compared with the bare metal stent group (0.7+/-0.7 mm, P=0.034). There was a trend of lower late loss in the stent graft group than in the bare metal stent group. CONCLUSION: Three groups of stents implanted in patients with acute coronary syndrome did not differ in the incidence of major adverse cardiac events. Sirolimus-eluting stents had a lower incidence of in-stent restenosis than bare metal stent group. Stent graft implanted in native coronary arteries appears to be safe and efficient in patients with acute coronary syndrome, but a significant reduction in in-stent restenosis was not achieved.
RCT Entities:
AIM: To compare polytetrafluoroethylene stent graft (PTFE) with sirolimus and bare metal stents in reducing in-stent restenosis in native coronary vessels in patients with acute coronary syndrome. METHODS: The study included patients who underwent stent implantation in acute coronary syndrome from January 2003 to May 2004. The patients (n=119) were randomized either to stent graft group (n=40), sirolimus eluting stent group (n=39), or bare metal stent group (n=40). The main outcome measure of the study was the incidence restenosis at 6-month. The secondary outcome was 6-month major adverse coronary event rate. RESULTS: The incidence of 6-month major adverse coronary events was similar in all three groups (8 events in stent graft, 9 in sirolimus eluting stent, and 16 in bare metal stent group events). The target lesion revascularization was higher in the bare metal stent group (P=0.044). Restenosis rate, at six-month follow-up was higher in the bare metal stent group compared with the stent graft and sirolimus eluting stent groups. The percent diameter stenosis in the follow-up was significantly higher in the bare metal stent group (P=0.005). The late loss was significantly lower in the sirolimus eluting stent group (mean+/-standard deviation, 0.2+/-0.5 mm), compared with the bare metal stent group (0.7+/-0.7 mm, P=0.034). There was a trend of lower late loss in the stent graft group than in the bare metal stent group. CONCLUSION: Three groups of stents implanted in patients with acute coronary syndrome did not differ in the incidence of major adverse cardiac events. Sirolimus-eluting stents had a lower incidence of in-stent restenosis than bare metal stent group. Stent graft implanted in native coronary arteries appears to be safe and efficient in patients with acute coronary syndrome, but a significant reduction in in-stent restenosis was not achieved.
Authors: Christian Spaulding; Patrick Henry; Emmanuel Teiger; Kevin Beatt; Ezio Bramucci; Didier Carrié; Michel S Slama; Bela Merkely; Andrejs Erglis; Massimo Margheri; Olivier Varenne; Ana Cebrian; Hans-Peter Stoll; David B Snead; Christoph Bode Journal: N Engl J Med Date: 2006-09-14 Impact factor: 91.245
Authors: Martin Schillinger; Petra Dick; Gerald Wiest; Stephan Gentzsch; Schila Sabeti; Markus Haumer; Andrea Willfort; Christian Nasel; Christian Wöber; Josef Zeitlhofer; Erich Minar Journal: J Endovasc Ther Date: 2006-06 Impact factor: 3.487
Authors: Francesco Saia; Pedro A Lemos; Chi-Hang Lee; Chourmouzios A Arampatzis; Angela Hoye; Muzaffer Degertekin; Kengo Tanabe; Georgios Sianos; Pieter C Smits; Eugene McFadden; Sjoerd H Hofma; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick W Serruys Journal: Circulation Date: 2003-10-13 Impact factor: 29.690
Authors: Goran Stankovic; Antonio Colombo; Patrizia Presbitero; Frank van den Branden; Luigi Inglese; Carmelo Cernigliaro; Luigi Niccoli; Antonio L Bartorelli; Paolo Rubartelli; Nicholaus Reifart; Guy R Heyndrickx; Kari Saunamäki; Marie Claude Morice; Fabio A Sgura; Carlo Di Mario Journal: Circulation Date: 2003-06-23 Impact factor: 29.690